Koru Medical Systems Inc Expected To Post A Loss Of 4 Cents A Share: Earnings Preview

Koru Medical Systems

11/03/2024 20:19

* KORU Medical Systems Inc  KRMD.OQ   KRMD.O  is expected
to show
a fall in quarterly revenue when it reports  results on March 13
for the period ending December 31 2023
    * The Mahwah New Jersey-based  company is expected to report
a
5.5% decrease in revenue to $6.944 million from $7.35 million a
year ago, according to the mean estimate from 5 analysts, based
on LSEG data.
    * ​LSEG's mean analyst estimate for KORU Medical Systems Inc
is
for a loss of 4 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for KORU
Medical
Systems Inc is $4.00​, above​ its last closing price of $2.21.
​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Sep. 30 2023  -0.06       -0.05      -0.03     Beat    40
 Jun. 30 2023  -0.06       -0.06      -0.05     Beat    11.8
 Mar. 31 2023  -0.04       -0.05      -0.05     Met     0​
 Dec. 31 2022  -0.06       -0.06      -0.04     Beat    29.4
 ​​Sep.        -0.05       -0.05      -0.03     Beat    43.7
 30 2022                                                
 Jun. 30 2022  -0.06       -0.07      -0.07     Met     0​
 Mar. 31 2022  -0.06       -0.06      -0.06     Met     -5.9
 Dec. 31 2021  -0.04       -0.03      -0.02     Beat    40
 This summary was machine generated March 11 at 20:19 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)